IE39216L - Pharmaceutical tablets - Google Patents
Pharmaceutical tabletsInfo
- Publication number
- IE39216L IE39216L IE740803A IE80374A IE39216L IE 39216 L IE39216 L IE 39216L IE 740803 A IE740803 A IE 740803A IE 80374 A IE80374 A IE 80374A IE 39216 L IE39216 L IE 39216L
- Authority
- IE
- Ireland
- Prior art keywords
- tablets
- weight
- pharmaceutical tablets
- penicillins
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1422176 Pharmaceutical tablets BEECHAM GROUP Ltd 1 May 1974 [5 May 1973 7 Dec 1973] 21502/73 and 56858/73 Heading A5B Pharmaceutical tablets comprise 10% to 70% by weight of heavy magnesium carbonate, 30% to 85% by weight of a semi-synthetic penicillin or cephalosparin which is suitable for oral administration and 0 to 40% by weight of conventional tabletting ingredients. The tablets may be produced by direct compression in a tablet press. Two different penicillins may be present in the tablets. The penicillins and cephalosparins may be cloxacillin, flucloxacillin, dicloxacillin, an α-ester of carbenicillin or ticarcillin, phenethicillin, propacillin, azidocillin, hetacillin, metampicillin, cyclocillin, epicillin, pivampicillin, talampicillin, cephalexin, cephadrine, ampicillin, amoxycillin and esters and salts thereof.
[GB1422176A]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2150273A GB1422176A (en) | 1973-05-05 | 1973-05-05 | Pharmaceutical tablets |
GB5685873 | 1973-12-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE39216L true IE39216L (en) | 1974-11-05 |
IE39216B1 IE39216B1 (en) | 1978-08-30 |
Family
ID=26255363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE803/74A IE39216B1 (en) | 1973-05-05 | 1974-04-17 | Pharmaceutical tablets |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5714649B2 (en) |
CA (1) | CA1018890A (en) |
DE (1) | DE2421273A1 (en) |
DK (1) | DK145712C (en) |
FR (1) | FR2227856B1 (en) |
GB (1) | GB1422176A (en) |
IE (1) | IE39216B1 (en) |
IL (1) | IL44646A (en) |
NL (1) | NL7406023A (en) |
SE (1) | SE402405B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH647676A5 (en) * | 1978-12-22 | 1985-02-15 | Donald E Panoz | ORAL, PROGRAM RELEASED GALENIC FORMS AND METHODS OF PREPARING THE SAME. |
DE3239592C2 (en) * | 1982-10-26 | 1986-10-30 | Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga | Antibacterial drug |
EP0221699B1 (en) * | 1985-10-19 | 1990-01-10 | Beecham Group Plc | Composition for the treatment of infections |
CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
US6749864B2 (en) | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
US5433959A (en) | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
GB9613470D0 (en) | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
IS7724A (en) * | 2005-03-02 | 2006-09-03 | Actavis Group | Composition of tablets with rapid decomposition containing heavy magnesium carbonate |
EP1728511A1 (en) * | 2005-05-31 | 2006-12-06 | Faust Pharmaceuticals | New use of phenethicillin and salts thereof. |
DK2531178T3 (en) * | 2010-02-03 | 2014-09-01 | Merck Patent Gmbh | DIRECT COMPRESSABLE MAGNESIUM HYDROXIDE CARBONATE |
WO2012124827A1 (en) * | 2011-03-17 | 2012-09-20 | 協和化学工業株式会社 | Binder for tablet forming |
-
1973
- 1973-05-05 GB GB2150273A patent/GB1422176A/en not_active Expired
-
1974
- 1974-04-16 IL IL44646A patent/IL44646A/en unknown
- 1974-04-17 IE IE803/74A patent/IE39216B1/en unknown
- 1974-04-26 FR FR7414543A patent/FR2227856B1/fr not_active Expired
- 1974-04-26 SE SE7405687A patent/SE402405B/en unknown
- 1974-05-02 DE DE2421273A patent/DE2421273A1/en not_active Withdrawn
- 1974-05-03 NL NL7406023A patent/NL7406023A/xx not_active Application Discontinuation
- 1974-05-03 CA CA198,938A patent/CA1018890A/en not_active Expired
- 1974-05-03 DK DK243274A patent/DK145712C/en not_active IP Right Cessation
- 1974-05-07 JP JP5066074A patent/JPS5714649B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2227856A1 (en) | 1974-11-29 |
NL7406023A (en) | 1974-11-07 |
JPS5029732A (en) | 1975-03-25 |
AU6853574A (en) | 1975-11-06 |
GB1422176A (en) | 1976-01-21 |
IL44646A0 (en) | 1974-06-30 |
DK145712C (en) | 1983-07-25 |
DE2421273A1 (en) | 1974-11-14 |
CA1018890A (en) | 1977-10-11 |
IE39216B1 (en) | 1978-08-30 |
IL44646A (en) | 1977-04-29 |
SE402405B (en) | 1978-07-03 |
JPS5714649B2 (en) | 1982-03-25 |
DK145712B (en) | 1983-02-07 |
FR2227856B1 (en) | 1978-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE39216B1 (en) | Pharmaceutical tablets | |
IE812232L (en) | Composition | |
IE37757B1 (en) | Penicillins and cephalosporins | |
ES408226A1 (en) | 1-(Quinazolinyl) indol-3-ylacetic acids, esters and amides | |
GB1471564A (en) | Direct compression tabletting composition and tablets produced therefrom | |
GB1380171A (en) | Medicinal tablets | |
GB1204580A (en) | Pharmaceutical dosage forms | |
GR3017547T3 (en) | Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient. | |
IE39741L (en) | Phenyl-benzoic acid pharmaceuticals | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
ES8301107A1 (en) | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant. | |
GB1439240A (en) | Chewable aspirin tablet | |
GB1371939A (en) | Pyridine carboxamides | |
GB1504426A (en) | Clavulanic acid derivatives | |
GB1417539A (en) | Pyrazolo-qzinoline derivative and compositions thereof | |
AU7071387A (en) | A pharmaceutical formulation containing indomethacin | |
CA1012159A (en) | Dialkylaminoalkyl esters of 2-(6-methoxy-2-naphthyl) propionic acid and the pharmaceutically acceptable salts thereof | |
GB1375806A (en) | ||
GB1368251A (en) | Theophylinylmethylethanoic acid ester | |
US3888848A (en) | Ampicillin-chloral hydrate complex | |
GB1291282A (en) | Improvements in pharmaceutical compositions | |
GB1275164A (en) | New heterocyclic carboxylic acids, process for their production and pharmaceutical preparations having a content thereof | |
IT1166614B (en) | 2-Methoxy-phenoxy:acetate of talampicillin - prepd. by hydrolysis of metampicillin phthalidyl ester in two-phase solvent and treatment of aq. phase with 2-methoxy-phenoxyacetic acid sal | |
GB1472086A (en) | Pharmaceutical composition for treatment of liver diseases | |
IL38864A (en) | Pharmaceutical compositions containing a pharmaceutically active penicillin and a penicilloic acid derivative |